Stuvia.com n- nThe nMarketplace nto nBuy nand nSell nyour nStudy
Material
Chapter 1: Indications for Pulmonary Function Testing
n n n n n n
Test Bank
n n
MULTIPLE CHOICE n
1. Who first popularized spirometry for the evaluation of pulmonary function?
n n n n n n n n n
a. August and Marie Krogh n n n
b. Alvan Barach n
c. John Severinghaus n
d. John Hutchinson n
ANS: D n n
Hutchinson popularized the concept of using VC to assess lung function, and the names he
n n n n n n n n n n n n n n
gave to several other lung compartments are still used today.
n n n n n n n n n n
DIF: 1 REF: p. 2 n OBJ: None MSC: NBRC: None
n n
2. Which of the following are indications for performing spirometry?
n n n n n n n n
1. Assess the risk of lung resection. n n n n n
2. Determine the response to bronchodilator therapy. n n n n n
3. Assess the severity of restrictive lung disease. n n n n n n
4. Quantify the extent of COPD. n n n n
a. 1 and 4 n n
b. 2 and 3 n n
c. 1, 2, and 4 n n n
d. 2, 3, and 4 n n n
ANS: C n n
Spirometry cannot assess severity of restriction; for that you need to measure lung volumes
n n n n n n n n n n n n n
(see Box 1-2, Chapter 1).
n n n n n
DIF: 1 REF: p. 7 n OBJ: EL-2 MSC: NBRC: None
n n
3. The main indication for the measurement of lung volumes is to do which of the following?
n n n n n n n n n n n n n n n
a. Diagnose or assess the severity of restriction. n n n n n n
b. Evaluate the severity of pulmonary hypertension. n n n n n
c. Determine the level of cardiopulmonary fitness. n n n n n
d. Assess the risk of abdominal surgical procedures. n n n n n n
ANS: A n n
The most common reason for measuring lung volumes is to identify restrictive lung disease.
n n n n n n n n n n n n n
DIF:
n 1 REF: p. 35 n OBJ: EL-2 MSC: NBRC: None
n n
4. DLCO measurements may be indicated to evaluate pulmonary involvement in which of the
n n n n n n n n n n n n
following systemic diseases?
n n n
a. Asthma
b. Sarcoidosis
c. Exertional hypoxemia n
DD
oDw
ownwlno
nla
lodaeddedbyb:yS
: nu
kAipsre
iharehA|||paaabbpbiieigeklciatlcyinh1@
2@
gmgm
aiilal.ciclo
.ocm
om
Distribution nof nthis ndocument nis nillegal
, Stuvia.com n- nThe nMarketplace nto nBuy nand nSell nyour nStudy
Material
d. Guillain-Barré syndrome n
ANS: B n n
Sarcoidosis is the only systemic disease listed that affects gas exchange.
n n n n n n n n n n
DIF: 1 REF: p. 9 | p. 19 | p. 21 | p. 35 n n n n n n n n n n OBJ: EL-2
MSC: NBRC: None
n n n
5. Blood gas analysis is used with patients with COPD to do which of the following?
n n n n n n n n n n n n n n
a. Monitor airway responsiveness. n n
b. Determine level of cardiopulmonary fitness. n n n n
c. Detect pulmonary hypertension. n n
d. Assess need for supplementary O2. n n n n
ANS: D n n
Blood gas analysis is most commonly used to determine the need for supplemental oxygen
n n n n n n n n n n n n n
and to manage patients who require ventilatory support.
n n n n n n n n
DIF: 2 REF: p. 15 n OBJ: EL-1
MSC: NBRC: CPFT 2A-2
n n n n
6. Which of the following cause emphysema?
n n n n n
1. 1-Antitrypsin deficiency n
2. Exposure to environmental pollutants n n n
3. Radiation therapy n
4. Cigarette smoking n
a. 1 and 2 n n
b. 3 and 4 n n
c. 1, 2, and 4 n n n
d. 2, 3, and 4 n n n
ANS: C n n
Emphysema is caused primarily by cigarette smoking. Some emphysema is caused by the
n n n n n n n n n n n n
absence of a protective enzyme. Chronic exposure to environmental pollutants can also
n n n n n n n n n n n n
contribute to the development of emphysema.
n n n n n n
DIF: 1 REF: p. 11 n OBJ: EL-3 | AL-2 n n MSC: NBRC: None n n
7. An adult patient complains of chest tightness and cough whenever he jogs in cold weather.
n n n n n n n n n n n n n n
These symptoms are consistent with which of the following?
n n n n n n n n n
a. Cystic fibrosis n
b. Asthma
c. Pulmonary hypertension n
d. Idiopathic pulmonary fibrosis n n
ANS: B n n
Agents or events that cause an asthmatic episode are called triggers (see Box 1-7, Chapter
n n n n n n n n n n n n n n
1). Antigens such as animal dander, pollens, and dusts are the most common triggers. Other
n n n n n n n n n n n n n n n
common triggers include exposure to air pollutants and exercise in cold or dry air.
n n n n n n n n n n n n n n
DIF: 2 REF: p. 16 n OBJ: EL-3 MSC: NBRC: None n n
DD
oDw
ownwlno
nla
lodaeddedbyb:yS
: nu
kAipsre
iharehA|||paaabbpbiieigeklciatlcyinh1@
2@
gmgm
aiilal.ciclo
.ocm
om
Distribution nof nthis ndocument nis nillegal
, Stuvia.com n- nThe nMarketplace nto nBuy nand nSell nyour nStudy
Material
8. Which of the following statements concerning tumors in the upper airway is true?
n n n n n n n n n n n n
a. There may be variable or fixed obstruction.
n n n n n n
b. Fixed obstruction will be present.
n n n n
c. Variable obstruction will be present. n n n n
d. Small airway obstruction will result.
n n n n
ANS: A n n
Tumors involving the upper airway may cause variable or fixed obstruction.
n n n n n n n n n n
DIF: 2 REF: p. 19 n OBJ: EL-2
MSC: NBRC: CPFT 3C-3
n n n n
9. Sarcoidosis is a systemic disorder that usually causes which of the following?
n n n n n n n n n n n
a. A restrictive ventilatory defect
n n n
b. An obstructive ventilatory defect
n n n
c. Hyperreactive airways n
d. Primary pulmonary hypertension n n
ANS: A n n
Restriction is often associated with the following: interstitial lung diseases, including
n n n n n n n n n n
idiopathic fibrosis, pneumoconioses, and sarcoidosis.
n n n n n
DIF: 1 REF: p. 19 | p. 21 n n n n OBJ: EL-3 MSC: NBRC: None
n n
10. For which of the following conditions might pulmonary function testing be contraindicated?
n n n n n n n n n n n
a. Vocal cord dysfunction n n
b. Untreated pneumothorax n
c. Congestive heart failure (CHF) n n n
d. Bronchiolitis obliterans n
ANS: B n n
Pulmonary function tests are usually contraindicated in the presence of pneumothorax.
n n n n n n n n n n
However, undiagnosed pneumothorax may present a risk if pulmonary function studies are
n n n n n n n n n n n n
performed.
n
DIF: 1 REF: p. 23 n OBJ: EL-4
MSC: NBRC: CPFT 2B-6
n n n n
11. Which of the following correctly describe(s) appropriate physical measurements before
n n n n n n n n n
pulmonary function testing?
n n n
1. Actual body weight should be used to calculate predicted values.
n n n n n n n n n
2. Standing height should be measured when the patient is barefoot.
n n n n n n n n n
3. Arm span should be used instead of height for a patient with kyphosis.
n n n n n n n n n n n n
4. Age should be recorded to the nearest decade (10 years).
n n n n n n n n n
a. 1 only
n
b. 2 and 3
n n
c. 1, 2, and 4
n n n
d. 1, 2, 3, and 4
n n n n
nANS: B n
DD
oDw
ownwlno
nla
lodaeddedbyb:yS
: nu
kAipsre
iharehA|||paaabbpbiieigeklciatlcyinh1@
2@
gmgm
aiilal.ciclo
.ocm
om
Distribution nof nthis ndocument nis nillegal
, Stuvia.com n- nThe nMarketplace nto nBuy nand nSell nyour nStudy
Material
Various physical measurements are required for estimating each patient’s expected level of
n n n n n n n n n n n
pulmonary function. Age to the nearest month, height to the nearest 0.1 cm, and weight are
n n n n n n n n n n n n n n n n
usually recorded in addition to the patient’s gender. Race or ethnic origin should also be
n n n n n n n n n n n n n n n
recorded. (Although body weight is recorded, it is not used to calculate predicted values.)
n n n n n n n n n n n n n n
DIF: 1 REF: p. 29 n OBJ: None
MSC: NBRC: CPFT 3A-20
n n n n
12. In addition to explaining the procedure for each pulmonary function test to the patient, the
n n n n n n n n n n n n n n
pulmonary function technologist should do which of the following?
n n n n n n n n n
a. Briefly explain the physiologic basis of the test.
n n n n n n n
b. Demonstrate the correct performance of the test maneuver. n n n n n n n
c. Limit feedback to the patient to reduce the placebo effect.
n n n n n n n n n
d. Explain the exact number of efforts that will be required for each test.
n n n n n n n n n n n n
ANS: B n n
In addition to a description of the test, the maneuver should always be demonstrated.
n n n n n n n n n n n n n
DIF: 1 REF: p. 32 n OBJ: None
MSC: NBRC: CPFT 2B-6
n n n n
13. The single-breath diffusing capacity test was first described by:
n n n n n n n n
a. John Severinghaus n
b. August and Marie Krogh n n n
c. Robert Hyatt n
d. Leland Clark n
ANS: B n n
The basis for the modern single-breath diffusing capacity (DLCO) test was described by
n n n n n n n n n n n n
August and Marie Krogh in 1911.
n n n n n n
DIF: 1 REF: p. 5 n OBJ: None MSC: NBRC: None n n
14. DLCO measurements may be indicated to evaluate gas exchange abnormality in which of the
n n n n n n n n n n n n n
following?
n
a. Ketoacidosis
b. Myasthenia gravis n
c. Interstitial lung disease n n
d. Bronchitis
ANS: C n n
The other options do not affect the alveolar capillary membrane interface.
n n n n n n n n n n
DIF: 1 REF: p. 9 n OBJ: EL-2 MSC: NBRC: None n n
15. Vocal cord dysfunction will typically affect the flow-volume loop in what way?
n n n n n n n n n n n
a. Blunt the expiratory portion of the curve
n n n n n n
b. Blunt both the inspiratory and expiratory portions of the curve
n n n n n n n n n
c. Blunt the inspiratory portion of the curve
n n n n n n
d. Have no effect on the curve but cause inspiratory stridor
n n n n n n n n n
DD
oDw
ownwlno
nla
lodaeddedbyb:yS
: nu
kAipsre
iharehA|||paaabbpbiieigeklciatlcyinh1@
2@
gmgm
aiilal.ciclo
.ocm
om
Distribution nof nthis ndocument nis nillegal
Material
Chapter 1: Indications for Pulmonary Function Testing
n n n n n n
Test Bank
n n
MULTIPLE CHOICE n
1. Who first popularized spirometry for the evaluation of pulmonary function?
n n n n n n n n n
a. August and Marie Krogh n n n
b. Alvan Barach n
c. John Severinghaus n
d. John Hutchinson n
ANS: D n n
Hutchinson popularized the concept of using VC to assess lung function, and the names he
n n n n n n n n n n n n n n
gave to several other lung compartments are still used today.
n n n n n n n n n n
DIF: 1 REF: p. 2 n OBJ: None MSC: NBRC: None
n n
2. Which of the following are indications for performing spirometry?
n n n n n n n n
1. Assess the risk of lung resection. n n n n n
2. Determine the response to bronchodilator therapy. n n n n n
3. Assess the severity of restrictive lung disease. n n n n n n
4. Quantify the extent of COPD. n n n n
a. 1 and 4 n n
b. 2 and 3 n n
c. 1, 2, and 4 n n n
d. 2, 3, and 4 n n n
ANS: C n n
Spirometry cannot assess severity of restriction; for that you need to measure lung volumes
n n n n n n n n n n n n n
(see Box 1-2, Chapter 1).
n n n n n
DIF: 1 REF: p. 7 n OBJ: EL-2 MSC: NBRC: None
n n
3. The main indication for the measurement of lung volumes is to do which of the following?
n n n n n n n n n n n n n n n
a. Diagnose or assess the severity of restriction. n n n n n n
b. Evaluate the severity of pulmonary hypertension. n n n n n
c. Determine the level of cardiopulmonary fitness. n n n n n
d. Assess the risk of abdominal surgical procedures. n n n n n n
ANS: A n n
The most common reason for measuring lung volumes is to identify restrictive lung disease.
n n n n n n n n n n n n n
DIF:
n 1 REF: p. 35 n OBJ: EL-2 MSC: NBRC: None
n n
4. DLCO measurements may be indicated to evaluate pulmonary involvement in which of the
n n n n n n n n n n n n
following systemic diseases?
n n n
a. Asthma
b. Sarcoidosis
c. Exertional hypoxemia n
DD
oDw
ownwlno
nla
lodaeddedbyb:yS
: nu
kAipsre
iharehA|||paaabbpbiieigeklciatlcyinh1@
2@
gmgm
aiilal.ciclo
.ocm
om
Distribution nof nthis ndocument nis nillegal
, Stuvia.com n- nThe nMarketplace nto nBuy nand nSell nyour nStudy
Material
d. Guillain-Barré syndrome n
ANS: B n n
Sarcoidosis is the only systemic disease listed that affects gas exchange.
n n n n n n n n n n
DIF: 1 REF: p. 9 | p. 19 | p. 21 | p. 35 n n n n n n n n n n OBJ: EL-2
MSC: NBRC: None
n n n
5. Blood gas analysis is used with patients with COPD to do which of the following?
n n n n n n n n n n n n n n
a. Monitor airway responsiveness. n n
b. Determine level of cardiopulmonary fitness. n n n n
c. Detect pulmonary hypertension. n n
d. Assess need for supplementary O2. n n n n
ANS: D n n
Blood gas analysis is most commonly used to determine the need for supplemental oxygen
n n n n n n n n n n n n n
and to manage patients who require ventilatory support.
n n n n n n n n
DIF: 2 REF: p. 15 n OBJ: EL-1
MSC: NBRC: CPFT 2A-2
n n n n
6. Which of the following cause emphysema?
n n n n n
1. 1-Antitrypsin deficiency n
2. Exposure to environmental pollutants n n n
3. Radiation therapy n
4. Cigarette smoking n
a. 1 and 2 n n
b. 3 and 4 n n
c. 1, 2, and 4 n n n
d. 2, 3, and 4 n n n
ANS: C n n
Emphysema is caused primarily by cigarette smoking. Some emphysema is caused by the
n n n n n n n n n n n n
absence of a protective enzyme. Chronic exposure to environmental pollutants can also
n n n n n n n n n n n n
contribute to the development of emphysema.
n n n n n n
DIF: 1 REF: p. 11 n OBJ: EL-3 | AL-2 n n MSC: NBRC: None n n
7. An adult patient complains of chest tightness and cough whenever he jogs in cold weather.
n n n n n n n n n n n n n n
These symptoms are consistent with which of the following?
n n n n n n n n n
a. Cystic fibrosis n
b. Asthma
c. Pulmonary hypertension n
d. Idiopathic pulmonary fibrosis n n
ANS: B n n
Agents or events that cause an asthmatic episode are called triggers (see Box 1-7, Chapter
n n n n n n n n n n n n n n
1). Antigens such as animal dander, pollens, and dusts are the most common triggers. Other
n n n n n n n n n n n n n n n
common triggers include exposure to air pollutants and exercise in cold or dry air.
n n n n n n n n n n n n n n
DIF: 2 REF: p. 16 n OBJ: EL-3 MSC: NBRC: None n n
DD
oDw
ownwlno
nla
lodaeddedbyb:yS
: nu
kAipsre
iharehA|||paaabbpbiieigeklciatlcyinh1@
2@
gmgm
aiilal.ciclo
.ocm
om
Distribution nof nthis ndocument nis nillegal
, Stuvia.com n- nThe nMarketplace nto nBuy nand nSell nyour nStudy
Material
8. Which of the following statements concerning tumors in the upper airway is true?
n n n n n n n n n n n n
a. There may be variable or fixed obstruction.
n n n n n n
b. Fixed obstruction will be present.
n n n n
c. Variable obstruction will be present. n n n n
d. Small airway obstruction will result.
n n n n
ANS: A n n
Tumors involving the upper airway may cause variable or fixed obstruction.
n n n n n n n n n n
DIF: 2 REF: p. 19 n OBJ: EL-2
MSC: NBRC: CPFT 3C-3
n n n n
9. Sarcoidosis is a systemic disorder that usually causes which of the following?
n n n n n n n n n n n
a. A restrictive ventilatory defect
n n n
b. An obstructive ventilatory defect
n n n
c. Hyperreactive airways n
d. Primary pulmonary hypertension n n
ANS: A n n
Restriction is often associated with the following: interstitial lung diseases, including
n n n n n n n n n n
idiopathic fibrosis, pneumoconioses, and sarcoidosis.
n n n n n
DIF: 1 REF: p. 19 | p. 21 n n n n OBJ: EL-3 MSC: NBRC: None
n n
10. For which of the following conditions might pulmonary function testing be contraindicated?
n n n n n n n n n n n
a. Vocal cord dysfunction n n
b. Untreated pneumothorax n
c. Congestive heart failure (CHF) n n n
d. Bronchiolitis obliterans n
ANS: B n n
Pulmonary function tests are usually contraindicated in the presence of pneumothorax.
n n n n n n n n n n
However, undiagnosed pneumothorax may present a risk if pulmonary function studies are
n n n n n n n n n n n n
performed.
n
DIF: 1 REF: p. 23 n OBJ: EL-4
MSC: NBRC: CPFT 2B-6
n n n n
11. Which of the following correctly describe(s) appropriate physical measurements before
n n n n n n n n n
pulmonary function testing?
n n n
1. Actual body weight should be used to calculate predicted values.
n n n n n n n n n
2. Standing height should be measured when the patient is barefoot.
n n n n n n n n n
3. Arm span should be used instead of height for a patient with kyphosis.
n n n n n n n n n n n n
4. Age should be recorded to the nearest decade (10 years).
n n n n n n n n n
a. 1 only
n
b. 2 and 3
n n
c. 1, 2, and 4
n n n
d. 1, 2, 3, and 4
n n n n
nANS: B n
DD
oDw
ownwlno
nla
lodaeddedbyb:yS
: nu
kAipsre
iharehA|||paaabbpbiieigeklciatlcyinh1@
2@
gmgm
aiilal.ciclo
.ocm
om
Distribution nof nthis ndocument nis nillegal
, Stuvia.com n- nThe nMarketplace nto nBuy nand nSell nyour nStudy
Material
Various physical measurements are required for estimating each patient’s expected level of
n n n n n n n n n n n
pulmonary function. Age to the nearest month, height to the nearest 0.1 cm, and weight are
n n n n n n n n n n n n n n n n
usually recorded in addition to the patient’s gender. Race or ethnic origin should also be
n n n n n n n n n n n n n n n
recorded. (Although body weight is recorded, it is not used to calculate predicted values.)
n n n n n n n n n n n n n n
DIF: 1 REF: p. 29 n OBJ: None
MSC: NBRC: CPFT 3A-20
n n n n
12. In addition to explaining the procedure for each pulmonary function test to the patient, the
n n n n n n n n n n n n n n
pulmonary function technologist should do which of the following?
n n n n n n n n n
a. Briefly explain the physiologic basis of the test.
n n n n n n n
b. Demonstrate the correct performance of the test maneuver. n n n n n n n
c. Limit feedback to the patient to reduce the placebo effect.
n n n n n n n n n
d. Explain the exact number of efforts that will be required for each test.
n n n n n n n n n n n n
ANS: B n n
In addition to a description of the test, the maneuver should always be demonstrated.
n n n n n n n n n n n n n
DIF: 1 REF: p. 32 n OBJ: None
MSC: NBRC: CPFT 2B-6
n n n n
13. The single-breath diffusing capacity test was first described by:
n n n n n n n n
a. John Severinghaus n
b. August and Marie Krogh n n n
c. Robert Hyatt n
d. Leland Clark n
ANS: B n n
The basis for the modern single-breath diffusing capacity (DLCO) test was described by
n n n n n n n n n n n n
August and Marie Krogh in 1911.
n n n n n n
DIF: 1 REF: p. 5 n OBJ: None MSC: NBRC: None n n
14. DLCO measurements may be indicated to evaluate gas exchange abnormality in which of the
n n n n n n n n n n n n n
following?
n
a. Ketoacidosis
b. Myasthenia gravis n
c. Interstitial lung disease n n
d. Bronchitis
ANS: C n n
The other options do not affect the alveolar capillary membrane interface.
n n n n n n n n n n
DIF: 1 REF: p. 9 n OBJ: EL-2 MSC: NBRC: None n n
15. Vocal cord dysfunction will typically affect the flow-volume loop in what way?
n n n n n n n n n n n
a. Blunt the expiratory portion of the curve
n n n n n n
b. Blunt both the inspiratory and expiratory portions of the curve
n n n n n n n n n
c. Blunt the inspiratory portion of the curve
n n n n n n
d. Have no effect on the curve but cause inspiratory stridor
n n n n n n n n n
DD
oDw
ownwlno
nla
lodaeddedbyb:yS
: nu
kAipsre
iharehA|||paaabbpbiieigeklciatlcyinh1@
2@
gmgm
aiilal.ciclo
.ocm
om
Distribution nof nthis ndocument nis nillegal
